DK1355655T5 - Præparater og fremgangsmåder til forbedring af nyrefunktion - Google Patents

Præparater og fremgangsmåder til forbedring af nyrefunktion

Info

Publication number
DK1355655T5
DK1355655T5 DK01997117T DK01997117T DK1355655T5 DK 1355655 T5 DK1355655 T5 DK 1355655T5 DK 01997117 T DK01997117 T DK 01997117T DK 01997117 T DK01997117 T DK 01997117T DK 1355655 T5 DK1355655 T5 DK 1355655T5
Authority
DK
Denmark
Prior art keywords
methods
zvegf4
preparations
mammal
renal function
Prior art date
Application number
DK01997117T
Other languages
English (en)
Other versions
DK1355655T3 (da
Inventor
Charles E Hart
Stavros Topouzis
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Publication of DK1355655T3 publication Critical patent/DK1355655T3/da
Application granted granted Critical
Publication of DK1355655T5 publication Critical patent/DK1355655T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK01997117T 2000-10-30 2001-10-26 Præparater og fremgangsmåder til forbedring af nyrefunktion DK1355655T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24447900P 2000-10-30 2000-10-30
PCT/US2001/050155 WO2002060467A2 (en) 2000-10-30 2001-10-26 Compositions and methods for improving kidney function

Publications (2)

Publication Number Publication Date
DK1355655T3 DK1355655T3 (da) 2007-01-15
DK1355655T5 true DK1355655T5 (da) 2007-08-13

Family

ID=22922950

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01997117T DK1355655T5 (da) 2000-10-30 2001-10-26 Præparater og fremgangsmåder til forbedring af nyrefunktion

Country Status (10)

Country Link
US (2) US6827938B2 (da)
EP (1) EP1355655B1 (da)
JP (1) JP4249482B2 (da)
AT (1) ATE339218T1 (da)
AU (1) AU2002248237A1 (da)
CA (1) CA2427143A1 (da)
DE (1) DE60123128T2 (da)
DK (1) DK1355655T5 (da)
ES (1) ES2272573T3 (da)
WO (1) WO2002060467A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135174B2 (en) * 2002-01-07 2006-11-14 Amgen Fremont, Inc. Antibodies directed to PDGFD and uses thereof
EP2358375B1 (en) * 2008-11-12 2013-07-24 Tengion, Inc. Isolated renal cells and uses thereof
KR102302069B1 (ko) 2010-11-10 2021-09-14 인리젠 장기 확대를 위한 주사가능 제제
US11123372B2 (en) 2016-07-29 2021-09-21 Prokidney Bioactive renal cells for the treatment of chronic kidney disease

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002534061A (ja) 1998-11-10 2002-10-15 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 血小板由来増殖因子ｄ、それをコードするｄｎａ、及びその利用法
AU4008500A (en) 1999-04-06 2000-10-23 Eli Lilly And Company Platelet-derived growth factor related gene and protein
US6468543B1 (en) * 1999-05-03 2002-10-22 Zymogenetics, Inc. Methods for promoting growth of bone using ZVEGF4
US6630142B2 (en) * 1999-05-03 2003-10-07 Zymogenetics, Inc. Method of treating fibroproliferative disorders
AU7868000A (en) 1999-10-07 2001-05-10 Curagen Corporation Growth factor polypeptides and nucleic acids encoding same
WO2001089450A2 (en) 2000-05-19 2001-11-29 Eli Lilly And Company Treating musculoskeletal disorders using lp85 and analogs thereof
US20020173453A1 (en) 2000-12-15 2002-11-21 Rama Akella Method of treating renal injury

Also Published As

Publication number Publication date
US6827938B2 (en) 2004-12-07
JP4249482B2 (ja) 2009-04-02
ES2272573T3 (es) 2007-05-01
EP1355655A2 (en) 2003-10-29
CA2427143A1 (en) 2002-08-08
US20050049217A1 (en) 2005-03-03
AU2002248237A1 (en) 2002-08-12
ATE339218T1 (de) 2006-10-15
WO2002060467A3 (en) 2003-08-21
US20020183273A1 (en) 2002-12-05
DK1355655T3 (da) 2007-01-15
JP2004518681A (ja) 2004-06-24
EP1355655B1 (en) 2006-09-13
WO2002060467A2 (en) 2002-08-08
DE60123128T2 (de) 2007-09-13
DE60123128D1 (de) 2006-10-26

Similar Documents

Publication Publication Date Title
YU71800A (sh) Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama
DE69820885D1 (de) Peptidsequenzen als scharnierregionen in proteinen wie immunglobulinfragmenten und ihre verwendung in der heilkunde
CY1117358T1 (el) ΔΙΑΛΥΤΗ ΓΛΥΚΟΠΡΩΤΕΪΝΗ ΥΑΛΟΥΡΟΝΙΔΑΣΗΣ (sHASEGP), ΔΙΑΔΙΚΑΣΙΑ ΓΙΑ ΤΗΝ ΠΑΡΑΣΚΕΥΗ ΤΗΣ, ΧΡΗΣΕΙΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΛΑΜΒΑΝΟΥΝ
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
ATE175446T1 (de) Immunogene peptide, antikörper sowie deren verwendungen im zusammenhang mit der cd4- rezeptorbindung
ES8506087A1 (es) Procedimiento para preparar proteina de uroquinasa humana bioactiva
WO2005021579A3 (en) Epo mimetic peptides and fusion proteins
PT835266E (pt) Superantigenios modificados / quimericos e seu uso
TR200003181T2 (tr) Gelişmiş çoğaltılabilirliğe sahip FAP alfa'ya özgü antikor
SE9901379D0 (sv) Receptor structures
DE69129803D1 (de) Wasserlösliche peptidanaloguen mit bindungstellen
Wilkinson The components of troponin from chicken fast skeletal muscle. A comparison of troponin T and troponin I from breast and leg muscle
NZ504548A (en) Polypeptides and nucleic acids encoding human chordin
DE69535719D1 (de) Fas-antigenbindender ligand
WO1999045098A3 (en) Delivery or proteins into eukaryotic cells with recombinant yersinia
EP1282722A4 (en) STABILIZED PROTEINS
DK0517829T4 (da) Forbedrede kimæriske toksiner
DK1355655T3 (da) Præparater og fremgangsmåder til forbedring af nyrefunktion
IL113252A0 (en) Eph receptors binding ligands
AU7980300A (en) Recombinant proteins and peptides for endotoxin biosensors, endotoxin removal, and anti-microbial and anti-endotoxin therapeutics
DE69635161D1 (de) Rekombinante hetero-multimerische proteine von dem alpha-beta c4 bp typ
ATE135407T1 (de) Peptide, welche hiv-retroviren-hemmende antikörper induzieren, sowie gegen diese peptide gerichtete antikörper
NZ507901A (en) Isolated myelin basic protein (MBP) for treating mutliple sclerosis
DK0938555T3 (da) Konstruktioner og komplekser af cyclin E
ATE260339T1 (de) Antikörper gegen menschliches restrictin